By Professor Herbert Herzog

Journal articles

Schwarzer C; Wittmann W; Schunk E; Kastenberger I; Gaburro S; Singewald N; Herzog H, 2009, 'Endogenous dynorphin in emotional control and stress response', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a39

Edelsbrunner M; Painsipp E; Herzog H; Holzer P, 2009, 'Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake', Neuropeptides, 43, pp. 491 - 497, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19781771

Edelsbrunner M; Herzog H; Holzer P, 2009, 'Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner', Behavioural Brain Research, 203, pp. 97 - 107

Tasan R; Lin SC; Hetzenauer A; Singewald N; Herzog H; Sperk G, 2009, 'Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice', Neuroscience, 158, pp. 1717 - 1730

Kastenberger I; Schunk E; Herzog H; Schwarzer C, 2009, 'Involvement of dynorphin in anxiogenic effects of estrogen', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a9

Lee NJ; Herzog H, 2009, 'NPY regulation of bone remodelling.', Neuropeptides, 43, pp. 457 - 463, http://dx.doi.org/10.1016/j.npep.2009.08.006

Teixeira L; Sousa D; Nunes A; Sousa M; Herzog H; Lamghari M, 2009, 'NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors', Journal of Cellular Biochemistry, 107, pp. 908 - 916

Sousa D; Herzog H; Lamghari M, 2009, 'NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target', Current Drug Targets, 10, pp. 9 - 19

Wittmann W; Schunk E; Rosskothen I; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2009, 'Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone', Neuropsychopharmacology, 34, pp. 775 - 785

Painsipp E; Herzog H; Holzer P, 2009, 'The gut-mood axis: a novel role of the gut hormone peptide YY on emotional-affective behaviour in mice', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a13

Verma D; Tasan RO; Herzog H; Sperk G, 2009, 'The role of NPY in expression and extinction of conditioned fear', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a33

Tilan JU; Everhart LM; Abe K; Kitlinska J; Herzog H; Zukowska Z, 2008, 'Megakaryocyte/platelet-derived Neuropeptide Y (NPY), in addition to neuronal, is essential for ischemic revascularization in rodents', FASEB JOURNAL, 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208467808113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong IPL; Zengin A; Herzog H; Baldock PA, 2008, 'Central regulation of bone mass', Seminars in Cell and Developmental Biology, 19, pp. 452 - 458, http://dx.doi.org/10.1016/j.semcdb.2008.08.001

Viardot AC; Heilbronn L; Herzog H; Gregersen S; Campbell LV, 2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24

Schunk E; Rosskothen I; Wittmann W; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2008, 'Behavioural characterization of prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a5

Karl T; Duffy L; Herzog H, 2008, 'Behavioural profile of a new mouse model for NPY deficiency', European Journal of Neuroscience, 28, pp. 173 - 180

Baldock PA; Wong I; Mcdonald M; Enriquez R; Scwarzer C; Little DG; Sainsbury-Salis A; Herzog H; Eisman JA, 2008, 'Endorphins regulate bone homeostasis by actions through dynorphin', Bone, 42, pp. S43 - S44, http://dx.doi.org/10.1016/j.bone.2007.12.070

Painsipp E; Herzog H; Holzer P, 2008, 'Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice', Neuropharmacology, 55, pp. 117 - 126

Tasan RO; Lin S; Hetzenauer A; Singewald N; Herzog H; Sperk G, 2008, 'Increased novelty-induced motor activity and reduced depression-like behavior in NPY Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a17

Rosskothen I; Schunk E; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2008, 'Influence of estrous cycle on explorative behaviour of wild-type and prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a6

Painsipp E; Herzog H; Sperk G; Holzer P, 2008, 'Long-term depression-like effect of a single immune challenge in neuropeptide Y Y2 and Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a39

Stanic D; Paratcha G; Ledda F; Herzog H; Kopin A; Hokfelt T, 2008, 'Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain', Proceedings of the National Academy of Sciences of the United States of America, 105, pp. 3610 - 3615, http://dx.doi.org/10.1073/pnas.0712303105

Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A, 2008, 'PYY transgenic mice are protected against diet-induced and genetic obesity.', Neuropeptides, 42, pp. 19 - 30, http://dx.doi.org/10.1016/j.npep.2007.11.003

Painsipp E; Wultsch T; Edelsbrunner M; Tasan R; Singewald N; Herzog H; Holzer P, 2008, 'Reduced anxiety-like and depression-related behavior in neuropeptide YY4 receptor knockout mice', Genes Brain and Behavior, 7, pp. 532 - 542

Doyle K; Karl T; Hort Y; Duffy L; Shine J; Herzog H, 2008, 'Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium', Journal of Neurochemistry, 105, pp. 641 - 652, http://dx.doi.org/10.1111/j.1471-4159.2007.05188.x

Lin EJD; Zhang L; Sainsbury A; Herzog H, 2007, 'Y2, Y4 receptors and obesity', Expert Review of Endocrinology and Metabolism, 2, pp. 163 - 173, http://dx.doi.org/10.1586/17446651.2.2.163

Kuo LE; Kitlinska JB; Tilan JU; Li L; Baker SB; Johnson MD; Lee EW; Burnett MS; Fricke ST; Kvetnansky R; Herzog H; Zukowska Z, 2007, 'Erratum: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome (Nature Medicine (2007) 13, (803-811))', Nature Medicine, 13, pp. 1120, http://dx.doi.org/10.1038/nm0907-1120

Kuo LE; Kitlinska JB; Tilan JU; Li L; Baker SB; Johnson MD; Lee EW; Burnett MS; Fricke ST; Kvetnansky R; Herzog H; Zukowska Z, 2007, 'Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome', Nature Medicine, 13, pp. 803 - 811, http://dx.doi.org/10.1038/nm1611

Lundberg P; Allison SJ; Lee NJ; Baldock PA; Brouard N; Rost S; Enriquez RF; Sainsbury A; Lamghari M; Simmons P; Eisman JA; Gardiner EM; Herzog H, 2007, 'Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.', J Biol Chem, 282, pp. 19082 - 19091, http://dx.doi.org/10.1074/jbc.M609629200

Baldock PA; Allison SJ; Lundberg P; Lee NJ; Slack K; Lin E-JD; Enriquez RF; McDonald MM; Zhang L; During MJ; Little DG; Eisman JA; Gardiner EM; Yulyaningsih E; Lin S; Sainsbury A; Herzog H, 2007, 'Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.', J Biol Chem, 282, pp. 19092 - 19102, http://dx.doi.org/10.1074/jbc.M700644200

Schwarzer C; Loacker S; Schunk E; Sayyah M; Herzog H, 2007, 'Anticonvulsant and neuroprotective actions of endogenous dynorphin', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a10

Karl T; Herzog H, 2007, 'Behavioral profiling of NPY in aggression and neuropsychiatric diseases', Peptides, 28, pp. 326 - 333

Sainsbury A; Lin S; McNamara K; Slack K; Enriquez R; Lee NJ; Boey D; Smythe GA; Schwarzer C; Baldock P; Karl T; Lin E-JD; Couzens M; Herzog H, 2007, 'Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice.', Mol Endocrinol, 21, pp. 1722 - 1735, http://dx.doi.org/10.1210/me.2006-0367

Loacker S; Sayyah M; Wittmann W; Herzog H; Schwarzer C, 2007, 'Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors', Brain, 130, pp. 1017 - 1028

Tasan RO; Weger S; Heilbronn R; Nguyen NK; Singewald N; Herzog H; Sperk G, 2007, 'Experiments to localize the site for the anxiogenic action of NPY mediated by Y2 receptors in the mouse brain', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a14

Lin S; Lin E-JD; Boey D; Lee NJ; Slack K; During MJ; Sainsbury A; Herzog H, 2007, 'Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways.', Endocrinology, 148, pp. 2056 - 2065, http://dx.doi.org/10.1210/en.2006-1408

Yuzuriha H; Inui A; Asakawa A; Ueno N; Kasuga M; Meguid M; Miyazaki J; Ninomiya M; Herzog H; Fujimiya M, 2007, 'Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development', Federation of American Societies for Experimantal Biology Journal, 21, pp. 2108 - 2112

Nadler JV; Tu B; Timofeeva O; Jiao Y; Herzog H, 2007, 'Neuropeptide Y in the recurrent mossy fiber pathway', Peptides, 28, pp. 357 - 364

Howell O; Silva S; Scharfman H; Sosunov A; Zaben M; Shatya A; Mckhann G; Herzog H; Laskowski A; Gray W, 2007, 'Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus', Neurobiology of Disease, 26, pp. 174 - 188

Wheway JE; Herzog H; Mackay F, 2007, 'NPY and receptors in immune and inflammatory diseases', Current Topics in Medicinal Chemistry, 7, pp. 1743 - 1752

Allison SJ; Baldock P; Herzog H, 2007, 'The control of bone remodeling by neuropeptide Y receptors', Peptides, 28, pp. 320 - 325

Boey D; Sainsbury A; Herzog H, 2007, 'The role of peptide YY in regulating glucose homeostasis', Peptides, 28, pp. 390 - 395

Wheway JE; Herzog H; Mackay F, 2007, 'The Y-1 receptor for NPY: A key modulator of the adaptive immune system', Peptides, 28, pp. 453 - 458

Johnen H; Lin S; Kuffner T; Brown DA; Tsai VW-W; Bauskin AR; Wu L; Pankhurst G; Jiang L; Junankar S; Hunter M; Fairlie WD; Lee NJ; Enriquez RF; Baldock PA; Corey E; Apple FS; Murakami MM; Lin E-J; Wang C; During MJ; Sainsbury A; Herzog H; Breit SN, 2007, 'Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.', Nat Med, 13, pp. 1333 - 1340, http://dx.doi.org/10.1038/nm1677

Allison SJ; Baldock P; Sainsbury A; Enriquez R; Lee NJ; Lin EJD; Klugmann M; During M; Eisman JA; Li M; Pan LC; Herzog H; Gardiner EM, 2006, 'Erratum: Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (Journal of Biological Chemistry (2006) 281, (23436-23444))', Journal of Biological Chemistry, 281, pp. 38966, http://dx.doi.org/10.1016/s0021-9258(20)71891-0

Baldock PA; Allison SJ; Herzog H; Gardiner EM, 2006, 'The Central Control of Bone Remodeling', , pp. 361 - 376, http://dx.doi.org/10.1016/B978-012088562-6/50022-4

Allison SJ; Baldock P; Sainsbury A; Enriquez R; Lee NJ; Lin E-JD; Klugmann M; During M; Eisman JA; Li M; Pan LC; Herzog H; Gardiner EM, 2006, 'Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice.', J Biol Chem, 281, pp. 23436 - 23444, http://dx.doi.org/10.1074/jbc.M604839200

Allison SJ; Herzog H, 2006, 'NPY and bone.', EXS, pp. 171 - 182, http://dx.doi.org/10.1007/3-7643-7417-9_13

Boey D; Herzog H, 2006, 'Peptide YY: Lessons from mouse models', Current Opinion in Endocrinology and Diabetes, 13, pp. 65 - 69, http://dx.doi.org/10.1097/01.med.0000200524.26578.3b

Sainsbury A; Bergen HT; Boey D; Bamming D; Cooney GJ; Lin S; Couzens M; Stroth N; Lee NJ; Lindner D; Singewald N; Karl T; Duffy L; Enriquez R; Slack K; Sperk G; Herzog H, 2006, 'Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice', Diabetes, 55, pp. 19 - 26, http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0472

Back to profile page